Cargando…
A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2
Human BST-2 inhibits HIV-1 replication by tethering nascent virions to the cell surface. HIV-1 codes Vpu that counteracts BST-2 by down-regulating this restriction factor from the cell surface. This important function makes Vpu a potential therapeutic target. Yet, no agents have been reported to blo...
Autores principales: | Mi, Zeyun, Ding, Jiwei, Zhang, Quan, Zhao, Jianyuan, Ma, Ling, Yu, Haisheng, Liu, Zhenlong, Shan, Guangzhi, Li, Xiaoyu, Zhou, Jinming, Wei, Tao, Zhang, Liguo, Guo, Fei, Liang, Chen, Cen, Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680884/ https://www.ncbi.nlm.nih.gov/pubmed/26669976 http://dx.doi.org/10.1038/srep18499 |
Ejemplares similares
-
2-thio-6-azauridine inhibits Vpu mediated BST-2 degradation
por: Zhang, Quan, et al.
Publicado: (2016) -
Identification of novel key amino acids at the interface of the transmembrane domains of human BST-2 and HIV-1 Vpu
por: Pang, Xiaojing, et al.
Publicado: (2013) -
Vpu and BST2: Still Not There Yet?
por: Sato, Kei, et al.
Publicado: (2012) -
Vpu Antagonizes BST-2–Mediated Restriction of HIV-1 Release via β-TrCP and Endo-Lysosomal Trafficking
por: Mitchell, Richard S., et al.
Publicado: (2009) -
Efficient BST2 antagonism by Vpu is critical for early HIV-1 dissemination in humanized mice
por: Dave, Vibhuti P, et al.
Publicado: (2013)